Skip to main content

Table 3 Percentage of GPs adjusting their treatment in case of diabetic co-morbidity

From: COPD exacerbations in general practice: variability in oral prednisolone courses

   Case 1 Case 2 Case 3 Case 4
   GOLD 1,2 no severe exacerbation GOLD 1,2, severe exacerbation GOLD 3,4, no severe exacerbation GOLD 3,4, severe exacerbation
  Adjustment:         
   N = 162 CI N = 157 CI N = 153 CI N = 154 CI
1. Higher total treatment dose 1% [0.001-0.044] 1% [0.002-0.045] 2% [0.004-0.056] 0% [0.000-0.000]
2. Lower total treatment dose 11% [0.067-0.170] 14% [0.090-0.204] 14% [0.087-0.202] 2% [0.004-0.056]
3. No treatment 3% [0.010-0.071] 0% [0.000-0.000] 1% [0.002-0.046] 0% [0.000-0.000]
4. Specialist treatment 0% [0.000-0.000] 5% [0.022-0.098] 0% [0.000-0.000] 10% [0.056-0.156]
  No adjustment:         
5. Both patients same total treatment dose 83% [0.053- 0.148] 69% [0.609-0.759] 83% [0.761-0.886] 25% [0.187-0.330]
6. Both patients no treatment 2% [0.004-0.053] 0% [0.000-0.000] 0% [0.000-0.000] 0% [0.000-0.000]
7. Both patients specialist line treatment 0% [0.000-0.000] 11% [0.064-0.168] 0% [0.000-0.000] 63% [0.548-0.706]
  1. CI = 95% confidence interval